HYSTINDO_Study of the vascularization of the vaginal slice after total laparoscopic hysterectomy, using indocyanine green injection.Prospective feasibility study
Phase 1
Active, not recruiting
- Conditions
- total hysterectomyMedDRA version: 20.0Level: PTClassification code: 10021151Term: Hysterectomy Class: 100000004865Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
- Registration Number
- CTIS2024-511467-28-00
- Lead Sponsor
- niversity Hospital Of Clermont-Ferrand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Adult patient, Patient requiring hysterectomy by surgical treatment accessible by laparoscopy
Exclusion Criteria
Protected patient, under guardianship, curatorship or legal protection, Patient refusal or poor understanding of the French language, Known allergy to iodine, Current pregnancy and breastfeeding, Intervention requiring the use of indocyanine green
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method